# VM110 in Detection of Microscopic Tumors: A Phase I Study

> **NCT03286062** · PHASE1 · TERMINATED · sponsor: **Fox Chase Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Ovarian Cancer
- Pancreatic Cancer

## Interventions

- **COMBINATION_PRODUCT:** Agent VM110 and laproscopic infra-red probe

## Key facts

- **NCT ID:** NCT03286062
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-12
- **Primary completion:** 2019-07-10
- **Final completion:** 2020-04-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2020-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03286062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03286062, "VM110 in Detection of Microscopic Tumors: A Phase I Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03286062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*